0001705246-20-000002.txt : 20200106
0001705246-20-000002.hdr.sgml : 20200106
20200106170038
ACCESSION NUMBER: 0001705246-20-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200106
DATE AS OF CHANGE: 20200106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Alan K.
CENTRAL INDEX KEY: 0001705246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 20510640
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_157834802099990.xml
FORM 4
X0306
4
2020-01-02
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001705246
Smith Alan K.
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
EVP, Technical Operations
Common Stock
2020-01-02
4
M
0
2344
A
6865
D
Common Stock
2020-01-02
4
F
0
883
1.51
D
5982
D
Common Stock
2020-01-03
4
M
0
1563
A
7545
D
Common Stock
2020-01-03
4
F
0
589
1.40
D
6956
D
Restricted Stock Units
2020-01-02
4
M
0
2344
0
D
Common Stock
2344.0
4687
D
Restricted Stock Units
2020-01-03
4
M
0
1563
0
D
Common Stock
1563.0
1562
D
Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of BLCM common stock.
Represents the number of shares withheld by and surrendered to the Issuer on January 2, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 2, 2018 for 9,375 shares.
Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 6,250 shares.
On January 2, 2018, the reporting person was granted 9,375 RSUs, of which 2,344 vested on January 2, 2020. The RSUs vest in four annual installments beginning January 2, 2019.
On January 3, 2017, the reporting person was granted 6,250 RSUs, of which 1,563 vested on January 3, 2020. The RSUs vest in four annual installments beginning January 3, 2018.
/s/ Alan K. Smith, Ph.D.
2020-01-06